R
Richard B. Kim
Researcher at University of Western Ontario
Publications - 380
Citations - 33088
Richard B. Kim is an academic researcher from University of Western Ontario. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 89, co-authored 328 publications receiving 30436 citations. Previous affiliations of Richard B. Kim include London Health Sciences Centre & St. Jude Children's Research Hospital.
Papers
More filters
Journal ArticleDOI
Genotype-guided dosing of vitamin K antagonists.
Journal Article
Repetitive Transcranial Magnetic Stimulation (TMS) for medication-resistant depression
Mark Abramowicz,Gianna Zuccotti,Jean Marie Pflomm,Susan M. Daron,Blaine M. Houst,Corinne E. Zanone,Carl W. Bazil,Vanessa K. Dalton,Eric J. Epstein,Sandip K. Mukherjee,Jordan W. Smoller,Jules Hirsch,David N. Juurlink,Richard B. Kim,Gerald L. Mandell,Hans Meinertz,Dan M. Roden,F. Estelle R. Simons,Neal H. Steigbigel,Donna Goodstein,Amy Faucard,Cynthia Macapagal Covey,Lauren K. Schwartz,Manouchkathe Cassagnol,Susie Wong,Liz Donohue,Cheryl Brown,Gene Carbona,Cristine Romatowski,Joanne F. Valentino,Yosef Wissner-Levy +30 more
TL;DR: The FDA has cleared a new device for treatment of major depressive disorder (MDD) resistant to antidepressant medication, the NeuroStar TMS System (Neuronetics), which produces pulsed magnetic fields that can induce electrical currents in the brain.
Journal ArticleDOI
Pretreatment HLADQA1-HLADRB1 Testing for the Prevention of Azathioprine-Induced Pancreatitis in Inflammatory Bowel Disease: A Prospective Cohort Study
Aze Wilson,Qian Wang,Yun-Hee Choi,Terry Ponich,James C. Gregor,Nilesh Chande,Brian Yan,Michael Sey,Melanie D. Beaton,Richard B. Kim +9 more
TL;DR: HLA DQA1-HLADRB1*07:01A>C screening was significantly associated with a reduction in the incidence of AZA-induced pancreatitis independent of weight, glucocorticoid exposure, and smoking status; however, using this strategy to guide the use of azathioprine therapy in IBD may eliminate a large proportion of patients from being eligible for treatment with azATHioprine.
Journal ArticleDOI
Genetic variation in the farnesoid X-receptor predicts Crohn's disease severity in female patients.
Aze Wilson,Qian Wang,Ahmed Almousa,Laura E. Jansen,Yun-Hee Choi,Ute I. Schwarz,Richard B. Kim +6 more
TL;DR: Unlike MDR1 and PXR, FXR-1GT genetic variation is associated with earlier and more frequent surgery in women with CD, which may be through ER-mediated attenuation of FXR activation.
Journal Article
A granisetron patch (Sancuso)
Mark Abramowicz,Gianna Zuccotti,Jean Marie Pflomm,Susan M. Daron,Blaine M. Houst,Corinne E. Zanone,Vanessa K. Dalton,Eric J. Epstein,Jules Hirsch,David N. Juurlink,Richard B. Kim,Gerald L. Mandell,Hans Meinertz,Dan M. Roden,F. Estelle R. Simons,Neal H. Steigbigel,Donna Goodstein,Amy Faucard,Cynthia Macapagal Covey,Lauren K. Schwartz,Manouchkathe Cassagnol,Cheryl Brown,Liz Donohue,Susie Wong,Gene Carbona,Cristine Romatowski,Joanne F. Valentino,Yosef Wissner-Levy +27 more